Analysis of purified protein derivative test results in patients with active tuberculosis before and after anti-tuberculosis therapy

Analysis of purified protein derivative test results in patients with active tuberculosis before and after anti-tuberculosis therapy

Bibliographic Details
Main Authors:	Jian-Gong Yang, Bing Huang, Ji-Cheng Wang, Yan-Xia Yin
Format:	Article
Language:	English
Published:	Elsevier 2022-03-01
Series:	Asian Journal of Surgery
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958421008198

Similar Items

Use of the 2,3-diacyl-trehalose and the purified protein derivative in the serodiagnosis of tuberculosis in AIDS
by: Maria Helena F Saad, et al.
Published: (1996-02-01)

Evaluation of Heating and Irradiation Methods for Production of Purified Protein Derivative (PPD) of Mycobacterium Tuberculosis
by: N. Mosavari, et al.
Published: (2021-01-01)

Proteomic characterisation of bovine and avian purified protein derivatives and identification of specific antigens for serodiagnosis of bovine tuberculosis
by: José Antonio Infantes-Lorenzo, et al.
Published: (2017-11-01)

Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy
by: Swiss Medical Weekly
Published: (2007-11-01)

Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons
by: Sergio Babudieri, et al.
Published: (2012-04-01)

Effect of the Inoculation Site of Bovine and Avian Purified Protein Derivatives (PPDs) on the Performance of the Intradermal Tuberculin Test in Goats From Tuberculosis-Free and Infected Herds
by: Javier Ortega, et al.
Published: (2021-08-01)

Purified Protein Derivative - PPD
by: Anastácio Q. Sousa, et al.

The change in blood glucose levels in tuberculosis patients before and during anti-tuberculosis treatment in China
by: Yan Lin, et al.
Published: (2017-01-01)

Immune Responses Following BCG Immunization of Infants in Uganda and United Kingdom Are Similar for Purified Protein Derivative but Differ for Secretory Proteins of Mycobacterium tuberculosis
by: Patrice A. Mawa, et al.
Published: (2021-03-01)

Proteins purified from Mycobacterium tuberculosis MDR and Susceptible clinical isolates: Identification by proteomics approach
by: A R. Hadizadeh Tasbiti, et al.
Published: (2015-01-01)

Frequency of Hepatotoxicity in Pulmonary Tuberculosis Patients taking Anti-Tuberculosis Therapy
by: Farkhanda Noureen, et al.
Published: (2017-07-01)

Risk factors of dyspeptic syndrome in patients staying in a tuberculosis in-patient unit and the state of intestinal microflora of patients before the start of anti-tuberculosis therapy
by: А. А. Kholodov, et al.
Published: (2022-05-01)

Screening people living with HIV before tuberculosis preventative therapy.
by: Godfrey-Faussett, P, et al.
Published: (1999)

Association of Mycobacterium tuberculosis infection test results with risk factors for tuberculosis transmission
by: Thara Venkatappa, et al.
Published: (2023-12-01)

Immunoinhibitory effects of anti-tuberculosis therapy induce the host vulnerability to tuberculosis recurrence
by: Isha Pahuja, et al.
Published: (2024-07-01)

Metabolic Changes of <i>Mycobacterium tuberculosis</i> during the Anti-Tuberculosis Therapy
by: Julia Bespyatykh, et al.
Published: (2020-02-01)

Purified protein derivative test and its booster phenomenon in patients with rheumatoid arthritis
by: Mansour Salesi, et al.
Published: (2015-01-01)

Diagnosis and Outcome of Tuberculosis of Knee Joint (Gonitis Tuberculosis) with Pulmonary Tuberculosis after Completing Anti-Tuberculosis Therapy: A Case Report
by: Anita Nur Charisma, et al.
Published: (2021-01-01)

Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals
by: Kristian Thorlund, et al.
Published: (2010-04-01)

Analysis of tuberculosis infection in children with negative results of the test with a recombinant tuberculosis antigen
by: Юлия Яровая, et al.
Published: (2019-09-01)

Problems of anti-tuberculosis therapy in patients on hemodialysis
by: O. M. Gordeeva, et al.
Published: (2022-07-01)

Duration of anti-tuberculosis therapy and timing of antiretroviral therapy initiation: association with mortality in HIV-related tuberculosis.
by: Claudia P Cortes, et al.
Published: (2013-01-01)

Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment
by: Farida Benhadou, et al.
Published: (2021-06-01)

Spontaneous emergence of multiple drug resistance in tuberculosis before and during therapy.
by: Caroline Colijn, et al.
Published: (2011-03-01)

T cell cytokine responses in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis following stimulation with proteins purified from Mycobacterium tuberculosis MDR clinical isolates
by: Alireza Hadizadeh Tasbiti, et al.
Published: (2016-01-01)

Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy
by: Yu Zhou, et al.
Published: (2017-10-01)

EVALUATION OF PSYCHOLOGICAL CHARACTERISTICS OF CHILDREN SUFFERING FROM RESPIRATORY TUBERCULOSIS AND RECEIVING ANTI-TUBERCULOSIS THERAPY
by: N. V. Zolotova, et al.
Published: (2015-09-01)

CHANGES IN THE MARKERS OF CARBOHYDRATE METABOLISM DURING ANTI-TUBERCULOSIS THERAPY IN TUBERCULOSIS PATIENTS WITH CONCURRENT DIABETES
by: R. Yu. Abdullaev, et al.
Published: (2019-02-01)

Proteomic analysis of protein purified derivative of Mycobacterium bovis
by: Sante Roperto, et al.
Published: (2017-04-01)

The use of anti-tuberculosis therapy for latent TB infection
by: Justin T Denholm, et al.
Published: (2010-07-01)

Study of Anti-tuberculosis Polyclonal Antibody and Its Potential As A Rapid Test Kit for Tuberculosis Detection
by: Muzaijadah Retno Arimbi
Published: (2018-03-01)

Long-term results of using the skin test with tuberculosis recombinant allergen for tuberculosis detection in Stavropol Region
by: O. D. Baronova, et al.
Published: (2019-05-01)

Changes of Mycobacterium tuberculosis specific antigen-stimulated CD27−CD38+IFN-γ+CD4+ T cells before and after anti-tuberculosis treatment
by: Yong Fang, et al.
Published: (2024-03-01)

Synthesis and characterization of polymeric derivatives of isoniazid as anti-tuberculosis drugs
by: Sivakamy Sunthiram
Published: (2014)

Synthesis and Anti–Mycobacterium tuberculosis Evaluation of Aza-Stilbene Derivatives
by: Fernando R. Pavan, et al.
Published: (2011-01-01)

Droplet based whole genome amplification for sequencing minute amounts of purified Mycobacterium tuberculosis DNA
by: Anzaan Dippenaar, et al.
Published: (2024-04-01)

Comparative analysis of eﬃcacy and safety of various anti-tuberculosis therapy regimens in patients with MDR/XDR tuberculosis
by: E. P. Myshkova, et al.
Published: (2022-06-01)

Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases.
by: Ifedayo M O Adetifa, et al.
Published: (2010-09-01)

Clinical Trial: Magnetoplasmonic ELISA for Urine-based Active Tuberculosis Detection and Anti-Tuberculosis Therapy Monitoring
by: Jeonghyo Kim, et al.
Published: (2021-10-01)

Identification of Serine 119 as an Effective Inhibitor Binding Site of M. tuberculosis Ubiquitin-like Protein Ligase PafA Using Purified Proteins and M. smegmatis
by: He-Wei Jiang, et al.
Published: (2018-04-01)